Influence of angiostatin and thalidomide on lymphangiogenesis

Lymphology

Volumn 38, Issue 3, 2005, Pages 146-155

  Shao, X J ^a   Chi, X Y ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; BIOCHEMICAL MARKER; HYALURONAN RECEPTOR; HYALURONIC ACID; LYMPHATIC ENDOTHELIUM HYALURONAN RECEPTOR 1; THALIDOMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; GROWTH INHIBITION; LYMPHANGIOGENESIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; THORACIC DUCT; TUMOR GROWTH; WOUND HEALING;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, LYMPHATIC; FLOW CYTOMETRY; LYMPHANGIOGENESIS; STAINING AND LABELING; SWINE; THALIDOMIDE;

EID: 27744521266     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Grossfeld, GD, SR Shi, DA Ginsberg, et al: Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. Histochem. Cytochem. 44 (1996), 761-766.
2. Achen MG, BK McColl, SA Stacker: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7 (2005), 121-127.
3. O'Reilly, MS, L Holmgren, Y Shing, et al: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994), 315-326.
4. Cao, Y, RW Ji, D Davidson, et al: Kringle domains of human angiostatin: Characterization of the anti-proliferation activity of endothelial cells. J. Biol. Chem. 271 (1996), 29461-29467.
5. Ji, WR, FJ Casstelline, Y Chang, et al: Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB 12 (1998), 1730-1738.
6. Nogueira, AC, R Neubert, A Felies, et al: Thalidomide derivatives and the immune system. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and their surface receptors on blood cells of marmosets. Life Sciences 58 (1995), 337-348.
7. D'Amato, RJ, MS Loughnan, E Flynn, et al: Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA. 91 (1994), 4082-4085.
8. Kenyon, BM, F Browne, RJ D'Amato: Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp. Eye Res. 64 (1997), 971-978.
9. Johnston, MG, MA Walker: Lymphatic endothelial and smooth-muscle cells in tissue culture. In Vitro 20 (1984), 566-572.
10. Iljin, K, MJ Karkkainen, EC Lawrence, et al: Vegfr-3 gene structure, regulatory region and sequence polymophisms. FASEB 15 (2001), 1028-1036.
11. Banerji, S, J Ni, SX Wang, et al: LYVE-1, a new homologue of the CD44 glucoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999), 789-801.
12. Mosmann, T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983), 55-63.
13. Logan, RP, A Robins, GA Tuner, et al: A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J. Immunol. Method 213 (1998), 19-30.
14. Lucas, R, L Holmgren, I Garcia, et al: Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92 (1998), 4730-4731.
15. Luo, JY, J Lin, G Paranya, et al: Angiostatin upregulates E-selectin in proliferating endothelial cells. Biochem. and Biophy. Res. Comm. 245 (1998), 906-911.
16. Moser, TL, MS Stack, I Asplin, et al: Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA 96 (1999), 2811-2816.
17. Chen, YH, HL Wu, CK Chen, et al: Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways. Biochem. and Biophy. Res. Comm. 310 (2003), 804-810.
18. Mattila, MM, JK Ruohola, T Karpanen, et al: VEGF-C induced lymphangiogenesis is associated with node metastasis in orthotopic MCCF-7 tumors. Int. J. Cancer 98 (2002), 946-951.
19. Cao, RH, MA Bjorndahl, P Religa, et al: PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6 (2004), 333-345.
20. Pytowski, B, J Goldman, K Persaud, et al: Complete and specific inhibition of adult lymphatic regeneration by a novel VEGF-3 neutralizing antibody. J. Natl. Cancer Inst. 97 (2005), 14-21.
21. Shao, XJ, FM Xie: Influence of angiogenesis inhibitor, endostatin and PF-4, on lymphangiogenesis. Lymphology 38 (2005), 1-8.